Messenger RNA, the key to personalised medicine
Palma Rocchi on LinkedIn: HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate…
PSMA-Targeted Radionuclide Therapy and salivary gland toxicity: why does it matter? | Journal of Nuclear Medicine
Palma Rocchi (palma0754) - Profile | Pinterest
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy | Journal of the American Chemical Society
Palma Rocchi - Group leader - Inserm | LinkedIn
Palma Rocchi (palma0754) - Profile | Pinterest
palma rocchi (@palmarocchi1) / X
Palma ROCCHI | Professor | French Institute of Health and Medical Research | Inserm | Research Center in Oncology of Marseille | Research profile
Integrative proteomic and phosphoproteomic profiling of prostate cell lines,PLOS ONE - X-MOL
Loop | Palma Rocchi
Robert Wilson's Ubu - Hauser & Wirth
Palma ROCCHI | Professor | French Institute of Health and Medical Research | Inserm | Research Center in Oncology of Marseille | Research profile
Sabrina Rocchi e Franco Naddei: omaggio a Jula De Palma • Gagarin Magazine
Nobel Prize for Medicine 2023 - Inserm Newsroom
UBU by Robert Wilson - Es Baluard
Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer - ScienceDirect
palma rocchi (@palmarocchi1) / X
PDF) Active-Targeted Nanotherapy Strategies for Prostate Cancer | Palma Rocchi - Academia.edu
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer: Molecular Therapy
Nanoparticules et ciblage thérapeutique | CRCM
Ubu — Robert Wilson
Loop | Palma Rocchi
Palma Rocchi - Group leader - Inserm | LinkedIn
